Literature DB >> 10073701

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

H J Bontkes, T D de Gruijl, J M Walboomers, J T Schiller, J Dillner, T J Helmerhorst, R H Verheijen, R J Scheper, C J Meijer.   

Abstract

To investigate whether there is an association between local or systemic IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like particles (VLP) containing L1 and L2 and the possible influence of these responses on clearance of HPV-16 and its associated lesions, cervical mucus samples from 125 patients and plasma samples from 100 patients, all participating in a non-intervention cohort study of women with abnormal cytology, were analysed. The results show that local IgG and IgA HPV-16 VLP-specific antibodies do not correlate with virus clearance. However, systemic IgG responses were more frequently detected in patients with a persistent infection (11/24) compared with patients with cleared HPV-16 infections (3/28, P = 0.006). Furthermore, the ultimate development of high-grade lesions was associated with systemic VLP-specific IgG reactivity (P = 0.026). By contrast, systemic IgA responses were correlated with virus clearance (7/28 clearance compared with 1/24 persistence patients, P = 0.06). This correlation was statistically significant when only those clearance patients who tested HPV-16 DNA-positive at more than one visit were included in the analysis (5/11 compared with 1/24, P = 0.007). As these systemic IgA responses were not accompanied by local IgA responses, the systemic IgA responses in HPV-16 clearance patients are suggested to be a by-product of a successful cellular immune response induced at the local lymph nodes, mediated by cytokines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073701     DOI: 10.1099/0022-1317-80-2-409

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Infection with Human Papillomavirus: Update on Epidemiology, Diagnosis, and Treatment.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination.

Authors:  Mirte Scherpenisse; Madelief Mollers; Rutger M Schepp; Chris J L M Meijer; Hester E de Melker; Guy A M Berbers; Fiona R M van der Klis
Journal:  Hum Vaccin Immunother       Date:  2012-11-13       Impact factor: 3.452

3.  Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.

Authors:  Jo-Ann S Passmore; Michelle Milner; Lynnette Denny; Candice Sampson; Dianne J Marais; Bruce Allan; Pam P Gumbi; Inga I Hitzeroth; Edward P Rybicki; Anna-Lise Williamson
Journal:  Immunology       Date:  2006-10-09       Impact factor: 7.397

4.  Overcoming Barriers to Cervical Cancer Screening Among Asian American Women.

Authors:  Carolyn Y Fang; Grace X Ma; Yin Tan
Journal:  N Am J Med Sci (Boston)       Date:  2011

5.  Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue.

Authors:  Renwei Chen; Peter Sehr; Tim Waterboer; Ilmo Leivo; Michael Pawlita; Antti Vaheri; Leena-Maija Aaltonen
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.

Authors:  Jennifer E Cameron; Isaac V Snowhite; Anil K Chaturvedi; Michael E Hagensee
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

7.  Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses.

Authors:  Yevgeniy Y Studentsov; Gloria Y F Ho; Morgan A Marks; Robert Bierman; Robert D Burk
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection.

Authors:  Agnihotram V Ramanakumar; Patricia Thomann; Joao M Candeias; Silvaneide Ferreira; Luisa L Villa; Eduardo L Franco
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

9.  Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasia.

Authors:  Carolyn Y Fang; Suzanne M Miller; Dana H Bovbjerg; Cynthia Bergman; Mitchell I Edelson; Norman G Rosenblum; Betsy A Bove; Andrew K Godwin; Donald E Campbell; Steven D Douglas
Journal:  Ann Behav Med       Date:  2008-02-13

10.  Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women.

Authors:  Dianne J Marais; Debbie Constant; Bruce Allan; Henri Carrara; Margaret Hoffman; Samuel Shapiro; Chelsea Morroni; Anna-Lise Williamson
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.